Some evidence suggests that CDK4/6 inhibition leads to an RB-dependent increase in reactive oxygen species (ROS) levels, resulting in the activation of autophagy and limitation of senescence in breast cancer cells.648. This evidence concerns the gene CDK4 and breast cancer.